Reporter July 26 2013

July 25, 2013

‘Bionic eye’ new option for retinitis pigmentosa patients

Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).

By Jessica Pasley
July 25, 2013

Pollen counts boost risk of rare drug reaction: study

High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.

By VUMC News and Communications
July 25, 2013

Visualizing data on network ‘maps’

The new web application NetGestalt will allow investigators to simultaneously visualize different types of data for the same gene – such as mutation, expression and modification.

By Leigh MacMillan
July 24, 2013

VU Stroke Center attains new level of certification

The Vanderbilt Stroke and Cerebrovascular Service has received advanced certification as a Comprehensive Stroke Center by The Joint Commission and the American Heart Association/American Stroke Association, one of only four in Tennessee.

By VUMC News and Communications
July 23, 2013

Vanderbilt to launch new flexible paid time off system for employees

In order to more effectively meet the broadly diverse work/life needs across employees’ life phases, Vanderbilt is moving to a modernized benefits plan called flexPTO.

By VUMC News and Communications
1 2